OptiNose’s (OPTN) Neutral Rating Reiterated at HC Wainwright

HC Wainwright restated their neutral rating on shares of OptiNose (NASDAQ:OPTN – Free Report) in a research report sent to investors on Friday morning, Marketbeat reports. The brokerage currently has a $9.00 target price on the stock, down from their previous target price of $18.00. Separately, Lake Street Capital downgraded shares of OptiNose from a […]

Leave a Reply

Your email address will not be published.

Previous post Franklin Covey’s (FC) “Outperform” Rating Reiterated at Barrington Research
Next post ICON Public (NASDAQ:ICLR) Cut to “Neutral” at The Goldman Sachs Group